These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 8515382)
1. Morning variations of plasma homovanillic acid in untreated schizophrenic patients. Zumárraga M; Andía I; Bárcena B; González-Torres MA; Dávila R J Psychiatr Res; 1993; 27(1):11-6. PubMed ID: 8515382 [TBL] [Abstract][Full Text] [Related]
2. Persistence of cyclicity of the plasma dopamine metabolite, homovanillic acid, in neuroleptic treated schizophrenic patients. Davila R; Zumarraga M; Andia I; Friedhoff AJ Life Sci; 1989; 44(16):1117-21. PubMed ID: 2565009 [TBL] [Abstract][Full Text] [Related]
3. Measurement of plasma homovanillic acid concentrations in schizophrenic patients. Kaminski R; Powchick P; Warne PA; Goldstein M; McQueeney RT; Davidson M Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(3):271-87. PubMed ID: 2193315 [TBL] [Abstract][Full Text] [Related]
4. Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation. Davidson M; Kahn RS; Powchik P; Warne P; Losonczy MF; Kaminsky R; Apter S; Jaff S; Davis KL Arch Gen Psychiatry; 1991 Jan; 48(1):73-6. PubMed ID: 1670618 [TBL] [Abstract][Full Text] [Related]
5. Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations. Davidson M; Kahn RS; Knott P; Kaminsky R; Cooper M; DuMont K; Apter S; Davis KL Arch Gen Psychiatry; 1991 Oct; 48(10):910-3. PubMed ID: 1929760 [TBL] [Abstract][Full Text] [Related]
6. Circadian variation of plasma homovanillic acid levels is attenuated by fluphenazine in patients with schizophrenia. Doran AR; Labarca R; Wolkowitz OM; Roy A; Douillet P; Pickar D Arch Gen Psychiatry; 1990 Jun; 47(6):558-63. PubMed ID: 2350208 [TBL] [Abstract][Full Text] [Related]
7. A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls. Davidson M; Davis KL Arch Gen Psychiatry; 1988 Jun; 45(6):561-3. PubMed ID: 3377642 [TBL] [Abstract][Full Text] [Related]
8. Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients. Pickar D; Labarca R; Linnoila M; Roy A; Hommer D; Everett D; Paul SM Science; 1984 Aug; 225(4665):954-7. PubMed ID: 6474162 [TBL] [Abstract][Full Text] [Related]
9. Catechol O-methyltransferase and monoamine oxidase A genotypes, and plasma catecholamine metabolites in bipolar and schizophrenic patients. Zumárraga M; Dávila R; Basterreche N; Arrue A; Goienetxea B; Zamalloa MI; Erkoreka L; Bustamante S; Inchausti L; González-Torres MA; Guimón J Neurochem Int; 2010; 56(6-7):774-9. PubMed ID: 20206656 [TBL] [Abstract][Full Text] [Related]
10. Longitudinal changes in symptoms and plasma homovanillic acid levels in chronically medicated schizophrenic patients. Suzuki E; Kanba S; Nibuya M; Adachi S; Sekiya U; Shintani F; Kinoshita N; Yagi G; Asai M Biol Psychiatry; 1994 Nov; 36(10):654-61. PubMed ID: 7880934 [TBL] [Abstract][Full Text] [Related]
11. Elevation of plasma homovanillic acid level can be detected within four hours after initiation of haloperidol treatment. Davila R; Zumarraga M; Perea K; Andia I; Friedhoff AJ Arch Gen Psychiatry; 1987 Sep; 44(9):837-8. PubMed ID: 3632258 [No Abstract] [Full Text] [Related]
12. Increments in plasma homovanillic acid concentrations after neuroleptic discontinuation are associated with worsening of schizophrenic symptoms. Khan RS; Amin F; Powchik P; Knott P; Goldstein M; Apter S; Kerman B; Jaff S; Davidson M Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(6):879-84. PubMed ID: 1980541 [TBL] [Abstract][Full Text] [Related]
13. Rapid and reliable high-performance liquid chromatographic method for analysing human plasma serotonin, 5-hydroxyindoleacetic acid, homovanillic acid and 3,4-dihydroxyphenylacetic acid. Cheng FC; Kuo JS; Chang WH; Juang DJ; Shih Y; Lai JS J Chromatogr; 1993 Aug; 617(2):227-32. PubMed ID: 7691858 [TBL] [Abstract][Full Text] [Related]
14. Plasma homovanillic acid concentration and the severity of schizophrenic illness. Davis KL; Davidson M; Mohs RC; Kendler KS; Davis BM; Johns CA; DeNigris Y; Horvath TB Science; 1985 Mar; 227(4694):1601-2. PubMed ID: 3975630 [TBL] [Abstract][Full Text] [Related]
15. Free and conjugated plasma homovanillic acid in schizophrenic patients. Garcia A; Galinowski A; Guicheney P; Mignot E; Loo H; Meyer P Biol Psychiatry; 1989 May; 26(1):87-96. PubMed ID: 2720023 [TBL] [Abstract][Full Text] [Related]
16. Evidence for a daily rhythm of plasma HVA in normal controls but not in schizophrenic patients. Doran AR; Pickar D; Labarca R; Douillet P; Wolkowitz OM; Thomas JW; Roy A; Paul SM Psychopharmacol Bull; 1985; 21(3):694-7. PubMed ID: 4034886 [No Abstract] [Full Text] [Related]
17. Plasma homovanillic acid in schizophrenics: supportive evidence for the two-subtype hypothesis. Chen TY; Lee CF; Lung FW; Lee TC; Lin WL; Hu WH; Yeh EK; Chang WH Taiwan Yi Xue Hui Za Zhi; 1989 Jun; 88(6):584-8. PubMed ID: 2571672 [TBL] [Abstract][Full Text] [Related]
18. Apomorphine has no effect on plasma homovanillic acid in schizophrenic patients. Davidson M; Kendler KS; Davis BM; Horvath TB; Mohs RC; Davis KL Psychiatry Res; 1985 Oct; 16(2):95-9. PubMed ID: 3865258 [TBL] [Abstract][Full Text] [Related]
19. Schizophrenic patients with deficit syndrome have higher plasma homovanillic acid concentrations and ventricular enlargement. Nibuya M; Kanba S; Sekiya U; Suzuki E; Matsuo Y; Kinoshita N; Shintani F; Yagi G; Asai M Biol Psychiatry; 1995 Jul; 38(1):50-6. PubMed ID: 7548472 [TBL] [Abstract][Full Text] [Related]
20. Diurnal variation in plasma homovanillic acid in patients with schizophrenia and healthy controls. Duncan E; Bollini AM; Sanfilipo M; Wieland S; Angrist B; Cooper TB; Rotrosen J Schizophr Res; 2006 Jan; 81(2-3):323-6. PubMed ID: 16181774 [No Abstract] [Full Text] [Related] [Next] [New Search]